Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Clinical Trials in Michigan

366 recruiting clinical trials across 15 cities in Michigan (MI). Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
366
Total Trials
366
Recruiting Now
15
Cities
20
Conditions

Recruiting Trials in Michigan

Clinical trial data sourced from ClinicalTrials.gov. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT00567073

Pompe Pregnancy Sub-Registry

This Sub-registry is a multicenter, international, longitudinal, observational, and voluntary program designed to track pregnancy outcomes for any pregnant woman enrolled in the...

Sponsor: Genzyme, a Sanofi CompanyEnrolling: 2020 locations
Glycogen Storage Disease Type II (GSD-II)Pompe Disease (Late-onset)Glycogenesis 2 Acid Maltase Deficiency
RECRUITINGNCT00748254

Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis

The purpose of this feasibility study is to determine if a new emerging technology called photoacoustic tomography (PAT) can be adapted for use in humans for the detection of...

Sponsor: University of MichiganEnrolling: 1131 location
Arthritis, Rheumatoid
RECRUITINGNCT00756665

Prostate Active Surveillance Study

The Prostate Active Surveillance Study (PASS) is a research study for men who have chosen active surveillance as a management plan for their prostate cancer. Active surveillance...

Sponsor: University of WashingtonEnrolling: 300011 locations
Prostatic Neoplasms
RECRUITINGNCT00935090

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

RATIONALE: Diagnostic procedures, such as 3'-deoxy-3'-\[18F\] fluorothymidine (FLT) PET imaging, may help find and diagnose cancer. It may also help doctors predict a patient's...

Sponsor: Barbara Ann Karmanos Cancer Institute1 location
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6
RECRUITINGNCT01209000

Nephrotic Syndrome Study Network

Minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), and Membranous nephropathy (MN), generate an enormous individual and societal financial burden, accounting...

Sponsor: University of MichiganEnrolling: 120020 locations
Minimal Change Disease (MCD)Membranous NephropathyGlomerulosclerosis, Focal Segmental
RECRUITINGNCT01241305

One-Time DNA Study for Vasculitis

The purpose of this study is to identify genes that increase the risk of developing vasculitis, a group of severe diseases that feature inflammation of blood vessels. Results of...

Sponsor: University of PennsylvaniaEnrolling: 100014 locations
Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss)Giant Cell ArteritisGranulomatosis With Polyangiitis (Wegener's)+3
RECRUITINGPhase 3NCT01804686

A Long-term Extension Study of PCI-32765 (Ibrutinib)

The purpose of this study is to collect long-term safety and efficacy data for participants treated with ibrutinib and to provide ongoing access to ibrutinib for participants who...

Sponsor: Janssen Research & Development, LLCEnrolling: 70020 locations
Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaMantle Cell Lymphoma+4
RECRUITINGNCT01904851

Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes

XLPAD is an observational study designed to evaluate the effectiveness and use of stent and non-stent based therapies among PAD patients. The study will create a registry that...

Sponsor: Baylor Research InstituteEnrolling: 1400020 locations
Peripheral Arterial Disease
RECRUITINGNCT01915511

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

The Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry started recruiting in 2014 with the objective of studying Idiopathic Pulmonary Fibrosis. In 2018, the...

Sponsor: Duke UniversityEnrolling: 300020 locations
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
RECRUITINGPhase 3NCT02000089

The Cancer of the Pancreas Screening-5 CAPS5)Study

Johns Hopkins clinical research office quality assurance group will monitor and audit this study at Johns Hopkins. The Sub Investigator at each site will be responsible for...

Sponsor: Johns Hopkins UniversityEnrolling: 90009 locations
Pancreas CancerPeutz-Jeghers Syndrome (PJS)Gene Mutation+2
RECRUITINGNCT02012699

Integrated Cancer Repository for Cancer Research

The iCaRe2 is a multi-institutional resource created and maintained by the Fred \& Pamela Buffett Cancer Center to collect and manage standardized, multi-dimensional, longitudinal...

Sponsor: University of NebraskaEnrolling: 99999920 locations
Pancreatic CancerThyroid CancerLung Cancer+47
RECRUITINGNCT02432560

Safety and Durability of Sirolimus for Treatment of LAM

The MIDAS study aims to follow male and female LAM patients who are currently taking, have previously failed or been intolerant of, or may (at some time in the future) take mTOR...

Sponsor: University of CincinnatiEnrolling: 60020 locations
Lymphangioleiomyomatosis
RECRUITINGPhase 3NCT02735707

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

REMAP-CAP is a randomised, embedded, multifactorial, adaptive platform trial for community-acquired pneumonia. The purpose of this study is to evaluate the effect of a range of...

Sponsor: UMC UtrechtEnrolling: 2000020 locations
Community-acquired Pneumonia, Influenza, COVID-19
RECRUITINGNCT03003299

PARTNER 3 Trial - Aortic Valve-in-Valve

This study will assess the safety and effectiveness of the SAPIEN 3/SAPIEN 3 Ultra transcatheter heart valve (THV) in patients with a failing aortic bioprosthetic valve.

Sponsor: Edwards LifesciencesEnrolling: 12520 locations
Aortic StenosisAortic Stenosis, Severe
RECRUITINGPhase 3NCT03016819

Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma...

THIS STUDY IS CURRENTLY RECRUITING PATIENTS WITH ALVEOLAR SOFT PART SARCOMA ONLY AND IS NO LONGER RECRUITING PATIENTS WITH SYNOVIAL SARCOMA OR LEIOMYOSARCOMA. This study...

Sponsor: Advenchen Laboratories, LLCEnrolling: 32520 locations
Alveolar Soft Part SarcomaLeiomyosarcomaSynovial Sarcoma+1
RECRUITINGPhase 2NCT03099356

Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer

This study will be a non-randomized pilot trial using Cyclophosphamide and Sirolimus for the treatment of metastatic differentiated thyroid cancer. Patients will be treated with...

Sponsor: University of Michigan Rogel Cancer CenterEnrolling: 221 location
Metastatic Thyroid Cancer
RECRUITINGPhase 1 / Phase 2NCT03128996

Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

This study is designed to estimate the efficacy and toxicity of familial HLA mismatched bone marrow transplants in patients with non-malignant disease who are less than 21 years...

Sponsor: Washington University School of MedicineEnrolling: 294 locations
Severe Sickle Cell DiseaseBone Marrow Failure SyndromesMetabolic Disorders+3
RECRUITINGPhase 1NCT03178149

A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due...

Age-related macular degeneration (AMD) is an eye disease which causes people to lose their sharp central vision over time. Aging damages the macula, which is in the middle of the...

Sponsor: Astellas Institute for Regenerative MedicineEnrolling: 4219 locations
Age-Related Macular Degeneration
RECRUITINGPhase 1 / Phase 2NCT03516708

Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer

The purpose of this research study is to evaluate epacadostat when given with routine radiation therapy and chemotherapy (capecitabine and oxaliplatin) to treat rectal cancer...

Sponsor: Washington University School of MedicineEnrolling: 494 locations
Rectal Cancer
RECRUITINGPhase 3NCT03588975

A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee

The objective of this study is to compare the efficacy and safety of MACI® vs arthroscopic microfracture in the treatment of patients aged 10 to 17 years with symptomatic...

Sponsor: Vericel CorporationEnrolling: 4512 locations
Chondral DefectOsteochondritis Dissecans (OCD)Articular Cartilage Defect+1
RECRUITINGPhase 3NCT03593759

Cardiac Sarcoidosis Randomized Trial

Prospective randomized controlled trial comparing low dose Prednisone(or Prednisolone)/Methotrexate combination to standard dose Prednisone(or Prednisolone) in patients diagnosed...

Sponsor: Ottawa Heart Institute Research CorporationEnrolling: 19420 locations
Cardiac SarcoidosisSarcoidosis
RECRUITINGNCT03604835

Mucopolysaccharidosis VII Disease Monitoring Program

The objectives of this study are to characterize MPS VII disease presentation and progression and assess long-term effectiveness and safety, including hypersensitivity reactions...

Sponsor: Ultragenyx Pharmaceutical INCEnrolling: 5014 locations
Mucopolysaccharidosis VIIMPS VIIMPS 7+1
RECRUITINGNCT03635645

Experimental and Clinical Studies of Retinal Stimulation

The study will evaluate new methods of retinal stimulation and training with the goal of improving the visual ability of retinal prosthesis participants.

Sponsor: University of MichiganEnrolling: 201 location
Retinitis Pigmentosa
RECRUITINGNCT03736382

Mild Intermittent Hypoxia and Its Multipronged Effect on Sleep Apnea

Mild intermittent hypoxia (IH) initiates sustained increases in chest wall and upper airway muscle activity in humans. This sustained increase is a form of respiratory plasticity...

Sponsor: Wayne State UniversityEnrolling: 402 locations
Obstructive Sleep ApneaSpinal Cord Injuries
RECRUITINGPhase 1 / Phase 2NCT03761108

Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma

The main purpose of this study is to learn about the safety of linvoseltamab and to find out what is the best dose of linvoseltamab to give to patients with multiple myeloma and...

Sponsor: Regeneron PharmaceuticalsEnrolling: 38720 locations
Multiple Myeloma
RECRUITINGNCT03871075

Intermittent Pneumatic Compression With and Without Exercise to Improve Functioning in Peripheral Artery Disease

The INTERCEDE randomized trial will establish whether six-months of intermittent pneumatic compression combined with walking exercise improves walking endurance at six-month...

Sponsor: Northwestern UniversityEnrolling: 2304 locations
Peripheral Artery Disease
RECRUITINGNCT03926520

Electroconvulsive Therapy (ECT) for Agitation in Dementia (AD)

This study will explore the effect of ECT treatments plus usual care (ECT+UC) in reducing severe agitation in patients with moderate to severe dementia including Alzheimer's...

Sponsor: Brent ForesterEnrolling: 505 locations
Alzheimer DementiaAgitation,Psychomotor
RECRUITINGNCT03941379

A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma

The purpose of this observational research study is to follow participants who have been treated with either bel-sar or received alternate treatment (sham, standard of care...

Sponsor: Aura BiosciencesEnrolling: 50016 locations
Choroidal MelanomaIndeterminate Lesions of Eye
RECRUITINGPhase 1 / Phase 2NCT03947385

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

This is a Phase 1/2, multi-center, open-label basket study designed to evaluate the safety and anti-tumor activity of IDE196 in patients with solid tumors harboring GNAQ or GNA11...

Sponsor: IDEAYA BiosciencesEnrolling: 33615 locations
Metastatic Uveal MelanomaCutaneous MelanomaColorectal Cancer+1
RECRUITINGEarly Phase 1NCT04008121

Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium

The objective of this study is to evaluate the safety and image quality of the investigational dye, MB-102, compared to the control dye (fluorescein sodium) in healthy and...

Sponsor: MediBeaconEnrolling: 101 location
RetinopathyRetinal Vein OcclusionDiabetic Retinopathy+1

Showing 30 of 366 trials in Michigan. Search all trials

Browse Trials by State

Frequently Asked Questions

There are currently 366 clinical trials actively recruiting participants in Michigan. These span all phases from early-stage Phase 1 to late-stage Phase 3 trials, across 20+ conditions.

The top conditions with recruiting trials in Michigan include Multiple Myeloma, Ovarian Cancer, Endometrial Cancer, Colorectal Cancer, Obstructive Sleep Apnea. Each has multiple active trials across research centers in the state.

Major trial sites in Michigan include Ann Arbor, Detroit, Grand Rapids, Farmington Hills, Royal Oak. Most large academic medical centers and research hospitals serve as trial sites.

Review the trial listings on this page and check the eligibility criteria — we translate them into plain English. When you find a trial that fits, talk to your doctor about whether it's right for you, then contact the trial team directly using the information on the trial page.

Sources: ClinicalTrials.gov
Last updated:

Trial data sourced from the ClinicalTrials.gov API. Location data reflects registered trial sites. This site does not provide medical advice.